The effect of family history of atherosclerosıs and other risk factors on changes in serum lipid levels in acne patients treated with isotretinoin
- 14 September 2024
- journal article
- research article
- Published by Springer Nature in Archives of Dermatological Research
- Vol. 316 (9) , 1-7
Abstract
Background Oral isotretinoin causes changes in serum lipid values. These changes are not seen in every patient, regardless of dose. It is unclear what causes these changes and how often serum lipid values should be followed up. Aims We aimed to evaluate the relationship between the change in serum lipid values and personal and familial risk factors. Methods Serum lipid values at baseline (0th), 1st, 3rd, and 6th months of isotretinoin treatment of acne patients aged 16 years and over using oral isotretinoin at a dose of 0.5-1 mg/kg/day between January 2017 and December 2019 were recorded retrospectively. The relationship between personal and familial risk factors and changes in serum lipid values were evaluated statistically. Results In pairwise comparison, a significant difference was detected between the 0th and 1st month, 0th and 3rd month, 0th and 6th month, and 1st and 6th month in the average serum lipid (Low-density lipoprotein (LDL), high-density lipoprotein (HDL), very low-density lipoprotein (VLDL), total cholesterol, triglyceride) levels. However, no significant difference was detected between 3rd and 6th month. The change in LDL levels between the 0th and the 3rd month was significantly higher in those with a family history of atherosclerosis than those without a family history of atherosclerosis (p = 0.034). The change in VLDL levels between the 0th and 6th month was significantly higher in those with a family history of atherosclerosis than those without a family history of atherosclerosis (p = 0.022). It was observed that the changes in total cholesterol and VLDL levels between the 0th and 3rd month increased as body mass index (BMI) increased (p = 0.03, p = 0.014, respectively). Similarly, the changes in triglyceride and VLDL levels between 0th and 6th month and between 1st and 6th month increased by an increase in BMI (respectively; p = 0.006, p = 0.019; p = 0.016, p = 0.022). The increase in the levels of VLDL between the 1st and the 6th month was found to be significantly higher in smokers than in non-smokers (p = 0,032). Conclusion We recommend evaluation of serum lipids values in the 0th, 1st, and 3rd month in all acne patients using oral isotretinoin and that these values have to be checked monthly in the following months for smokers, those with a history of atherosclerosis, and those with a BMI above normal.Keywords
This publication has 21 references indexed in Scilit:
- Isotretinoin-Induced Dyslipidemia: a Single-Center Study in Saudi ArabiaPatient Preference and Adherence, 2024
- Analysis of data with dependent measures in clinical and experimental studiesJornal Vascular Brasileiro, 2023
- Isotretinoin Induced Hyperlipidemia and Impact of Leptin Gene rs 7799039 Polymorphism in Safety of Acne PatientsPharmacogenomics and Personalized Medicine, 2021
- CorrectionJournal of the American Academy of Dermatology, 2020
- The Association between Adiponectin Single Nucleotide Polymorphisms and Side Effects of Isotretinoin in Acne PatientsDermatology Research and Practice, 2020
- The clinical utility of laboratory monitoring during isotretinoin therapy for acne and changes to monitoring practices over timeJournal of the American Academy of Dermatology, 2020
- Efficacy and adverse events of oral isotretinoin for acne: a systematic reviewBritish Journal of Dermatology, 2017
- Association between alcohol intake, overweight, and serum lipid levels and the risk analysis associated with the development of dyslipidemiaJournal of Clinical Lipidology, 2014
- Impact of body mass index on cholesterol levels of Japanese adultsInternational Journal Of Clinical Practice, 2006
- Effects of isotretinoin therapy on lipoprotein (a) serum LevelsInternational Journal of Dermatology, 1997